The receptor for advanced glycation end products is a sensor for cell‐free heme
暂无分享,去创建一个
S. Lancel | J. Dimitrov | M. Billamboz | N. Merle | L. Roumenina | M. Howsam | Alina Ghinet | E. Boulanger | L. Yatime | Charles Paul-Constant | Marie Frimat | Florian Delguste | Marie V. Daugan | O. May | A. Ghinet
[1] M. Bozza,et al. Mitochondrial Reactive Oxygen Species Participate in Signaling Triggered by Heme in Macrophages and upon Hemolysis , 2020, The Journal of Immunology.
[2] M. S. Milella,et al. Ligand Binding , 2020, Definitions.
[3] Jianjun Hu,et al. Identification of a Heme Activation Site on the MD-2/TLR4 Complex , 2019, Frontiers in Immunology.
[4] M. Lecerf,et al. Method for identification of heme-binding proteins and quantification of their interactions , 2019, bioRxiv.
[5] L. Roumenina,et al. Hemolysis Derived Products Toxicity and Endothelium: Model of the Second Hit , 2019, Toxins.
[6] E. Boulanger,et al. The receptor for advanced glycation end-products (RAGE) is an important pattern recognition receptor (PRR) for inflammaging , 2019, Biogerontology.
[7] J. Dimitrov,et al. P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner , 2019, Proceedings of the National Academy of Sciences.
[8] M. Zámocký,et al. Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease , 2018, Neural regeneration research.
[9] V. Čokić,et al. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms , 2018, Cellular Oncology.
[10] T. Salo,et al. Role of the high mobility group box 1 signalling axes via the receptor for advanced glycation end‐products and toll‐like receptor‐4 in the immunopathology of oral lichen planus: a potential drug target? , 2018, European journal of oral sciences.
[11] S. Miescher,et al. Characterization of Renal Injury and Inflammation in an Experimental Model of Intravascular Hemolysis , 2018, Front. Immunol..
[12] R. Bonomo,et al. Diabetes Exacerbates Infection via Hyperinflammation by Signaling through TLR4 and RAGE , 2017, mBio.
[13] A. Gee,et al. Targeting the Receptor for Advanced Glycation Endproducts (RAGE): A Medicinal Chemistry Perspective , 2017, Journal of medicinal chemistry.
[14] F. Costa,et al. Tissue factor-dependent coagulation activation by heme: A thromboelastometry study , 2017, PloS one.
[15] Emily A. Smith,et al. Ligand binding affinity and changes in the lateral diffusion of receptor for advanced glycation endproducts (RAGE). , 2016, Biochimica et biophysica acta.
[16] A. Schmidt,et al. Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling. , 2016, Structure.
[17] S. Lacroix-Desmazes,et al. Heme: Modulator of Plasma Systems in Hemolytic Diseases. , 2016, Trends in molecular medicine.
[18] S. Susen,et al. Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. , 2015, Molecular nutrition & food research.
[19] Min Chen,et al. High mobility group box 1 contributes to anti-neutrophil cytoplasmic antibody-induced neutrophils activation through receptor for advanced glycation end products (RAGE) and Toll-like receptor 4 , 2015, Arthritis Research & Therapy.
[20] A. Gruber,et al. Excess of heme induces tissue factor-dependent activation of coagulation in mice , 2015, Haematologica.
[21] D. Golenbock,et al. Hemolysis-induced lethality involves inflammasome activation by heme , 2014, Proceedings of the National Academy of Sciences.
[22] A. Alayash,et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. , 2014, Blood.
[23] G. R. Andersen,et al. Structural insights into the oligomerization mode of the human receptor for advanced glycation end‐products , 2013, The FEBS journal.
[24] G. Vercellotti,et al. Heme Potently Stimulates Tissue Factor Expression By Peripheral Blood Monocytes: A Novel Mechanism For Thrombosis In Intravascular Hemolytic Diseases , 2013 .
[25] J. Dimitrov,et al. Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome. , 2013, Blood.
[26] Ellen T. Gelfand,et al. The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.
[27] Zhao-xia Wang,et al. Heparanase induced by advanced glycation end products (AGEs) promotes macrophage migration involving RAGE and PI3K/AKT pathway , 2013, Cardiovascular Diabetology.
[28] D. Golenbock,et al. Heme induces programmed necrosis on macrophages through autocrine TNF and ROS production. , 2012, Blood.
[29] B. Atanasov,et al. Heme Interacts with C1q and Inhibits the Classical Complement Pathway* , 2011, The Journal of Biological Chemistry.
[30] K. Tsuneyama,et al. Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS , 2011, The Journal of Immunology.
[31] Ting Li,et al. Structural analysis of heme proteins: implications for design and prediction , 2010, 2010 IEEE International Conference on Bioinformatics and Biomedicine Workshops (BIBMW).
[32] U. Lopes,et al. Heme Amplifies the Innate Immune Response to Microbial Molecules through Spleen Tyrosine Kinase (Syk)-dependent Reactive Oxygen Species Generation* , 2010, The Journal of Biological Chemistry.
[33] Z. Chang. Important aspects of Toll-like receptors, ligands and their signaling pathways , 2010, Inflammation Research.
[34] Alan W. Stitt,et al. Homodimerization Is Essential for the Receptor for Advanced Glycation End Products (RAGE)-mediated Signal Transduction* , 2010, The Journal of Biological Chemistry.
[35] Haichao Wang,et al. High-mobility group box 1 protein induces tissue factor expression in vascular endothelial cells via activation of NF-κB and Egr-1 , 2009, Thrombosis and Haemostasis.
[36] L. Chau,et al. Hemin promotes proliferation and differentiation of endothelial progenitor cells via activation of AKT and ERK , 2009, Journal of cellular physiology.
[37] R. Hoffmann,et al. Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)* , 2008, Journal of Biological Chemistry.
[38] S. Kaveri,et al. Antibodies Use Heme as a Cofactor to Extend Their Pathogen Elimination Activity and to Acquire New Effector Functions* , 2007, Journal of Biological Chemistry.
[39] Tatiana P. Dutra,et al. Heme Induces Neutrophil Migration and Reactive Oxygen Species Generation through Signaling Pathways Characteristic of Chemotactic Receptors* , 2007, Journal of Biological Chemistry.
[40] R. Figueiredo,et al. Characterization of Heme as Activator of Toll-like Receptor 4* , 2007, Journal of Biological Chemistry.
[41] Jon Marles-Wright,et al. Diversity and conservation of interactions for binding heme in b-type heme proteins. , 2007, Natural product reports.
[42] Sanjay Kumar,et al. Free heme toxicity and its detoxification systems in human. , 2005, Toxicology letters.
[43] L. Goodglick,et al. Identification of genes differentially expressed in rat alveolar type I cells. , 2004, American journal of respiratory cell and molecular biology.
[44] M. Nakajima,et al. The receptor for advanced glycation end‐products (RAGE) directly binds to ERK by a D‐domain‐like docking site , 2003, FEBS letters.
[45] 홀덴 데이비드윌리암,et al. Identification of genes , 1995 .
[46] Y. Zou,et al. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. , 1993, The American journal of pathology.
[47] P. Jensen,et al. Supplemental Information The Structure of the RAGE : S 100 A 6 Complex Reveals a Unique Mode of Homodimerization for S 100 Proteins , 2022 .